"Oh and the other thing that was clear, correct me if I am wrong, is there was no notable synergistic effects with any statins?"

Subgroup event rates. Atorvastatin subgroup actually had better absolute and relative risk reduction. Opposite of what we were expecting.

Rosuvastatin, apabetalone vs. placebo: 10.5% vs. 12.1%

Atorvastatin, apabetalone vs. placebo: 10.1% vs. 12.6%